79 results
Page 2 of 4
8-K
EX-99.6
csz ihi7ou1qdeol
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
424B3
pnn6vf6yue3ho2yup78
10 Nov 22
Prospectus supplement
4:21pm
425
6r33pw
27 Oct 22
Business combination disclosure
7:15am
8-K
EX-99.1
0z0alz523
27 Oct 22
Kineta to Present Pre-clinical Data on VISTA and CD27 Programs at SITC 2022 Annual Meeting
7:13am
425
pllpp
13 Oct 22
Business combination disclosure
4:03pm
8-K
EX-99.1
9of pyps7tcb
13 Oct 22
Kineta to Present Anti-CD27 Agonist Preclinical Program at AACR Conference on Tumor Immunology and Immunotherapy
4:01pm
425
kucme5jed5idi536n
4 Oct 22
Business combination disclosure
4:04pm
8-K
EX-99.1
iuyv5
4 Oct 22
Kineta Appoints Keith Baker as Chief Financial Officer
4:01pm
425
00vwwxfqu9 h1
14 Sep 22
Business combination disclosure
4:04pm
8-K
EX-99.1
3okbd2n gz4imjau
14 Sep 22
Kineta CSO Thierry Guillaudeux Invited to Participate at the 2nd Annual VISTA Virtual Symposium
4:01pm
425
fz1vitd
12 Sep 22
Business combination disclosure
4:01pm
8-K
EX-99.1
ftcv99 3u
12 Sep 22
Kineta Announces Participation in the H.C. Wainwright 24th Annual Global Healthcare Conference
4:00pm
425
4uc3m6h c7
28 Jun 22
Business combination disclosure
4:03pm
8-K
EX-99.1
uf05i0
28 Jun 22
Kineta Announces Appointment of Thierry Guillaudeux, PhD to Chief Scientific Officer
4:02pm